The Bosnian Journal of Basic Medical Sciences has retracted a paper it published in August by Turkish researchers on the potential cancer risks associated with exposure to electromagnetic fields, or EMFs.
The reason: Other people wrote nearly all of it.
According to an editor’s notice: Continue reading Sultans of swap: Turkish researchers plagiarized electromagnetic fields-cancer paper, apparently others
Joachim Boldt, a leading German anesthesiologist who had a 2009 paper in Anesthesia & Analgesia retracted last month* amid allegations that he had misrepresented parts of the study, has been relieved of his duties as chief physician at Ludwigshafen Hospital.
A press release from the German Society for Anesthesiology and Intensive Care Medicine (DGAI) condemns Boldt’s actions. The press release goes on (translated from German): Continue reading After misrepresentation allegations, German anesthesiologist Joachim Boldt out as hospital’s chief physician
Self-plagiarism alert: A very similar version of this post is being published online in Anesthesiology News, where one of us (AM) is managing editor.
If a plagiarist plagiarizes from an author who herself has plagiarized, do we call it a wash and go for a beer?
That scenario is precisely what Steven L. Shafer found himself facing recently. Shafer, editor-in-chief of Anesthesia & Analgesia (A&A), learned that authors of a 2008 case report in his publication had lifted two-and-a-half paragraphs of text from a 2004 paper published in the Canadian Journal of Anesthesia.
A contrite retraction letter, which appears in the December issue of A&A, from the lead author, Sushma Bhatnagar, of New Delhi, India, called the plagiarism “unintended” and apologized for the incident. Straightforward enough.
But then things get sticky. Continue reading Plagiarists plagiarized: A daisy chain of retractions at Anesthesia & Analgesia
Anil Potti, who resigned from his post at Duke today during an investigation into faked results, will likely have another retraction to his credit shortly. According to a Duke statement:
Dr. Potti’s collaborator, Joseph Nevins, Ph.D., has initiated a process intended to lead to a retraction request regarding a paper previously published in Nature Medicine. This process has been initiated due to concerns about the reproducibility of reported predictors, and their possible effect on the overall conclusions in this paper. Other papers published based on this science are currently being reviewed for any concerns. Continue reading Another update on Anil Potti: Co-author asks Nature Medicine to retract paper
Duke’s Anil Potti, the Duke cancer researcher who falsely claimed to be a Rhodes Scholar and may have faked several analyses of chemotherapy and cancer, has resigned from the university.
The Duke Chronicle reports that Potti
…stepped down from his position at Duke’s Institute for Genome Sciences and Policy Friday and took responsibility for the problems in his research, IGSP Director Huntington Willard wrote in an e-mail to IGSP staff.
Willard wrote that Potti “accepted full responsibility for a series of anomalies in data handling, analysis and management that have come under scrutiny in the past months.”
He said that investigations into Potti’s research will continue, as will IGSP’s examinations of Potti’s science.
The resignation follows the retraction earlier this week of one paper Potti co-authored in the Journal of Clinical Oncology.
We’ll update as we learn more.
Please see an update about a second paper now being retracted by one of Potti’s co-authors.
We have a follow-up to our post two weeks ago about a possible retraction in the case of Anil Potti, the Duke cancer researcher who falsely claimed to be a Rhodes Scholar and may have also faked an analysis of how breast cancer responds to chemotherapy.
In that post, we noted that the Raleigh News & Observer had reported that one of Potti’s collaborators, Duke’s Joseph Nevins, had requested that a 2007 paper they co-authored be retracted. The journal told us this morning that the retraction went live yesterday. In it, the authors write: Continue reading JCO makes it official, retracting paper co-authored by Anil Potti
In our very first post, we noted the case of Anil Potti,
a Duke researcher who posed as a Rhodes Scholar and appears to have invented key statistical analyses in a study of how breast cancer responds to chemotherapy[.The case] has sent ripples of angst through the cancer community. Potti’s antics prompted editors of The Lancet Oncology to issue an “expression of concern” — a Britishism that might be better expressed as “Holy Shit!” — about the validity of a 2007 paper in their journal by Potti and others.
There hasn’t been any further movement on The Lancet Oncology study, as far as we know, but on Friday the Raleigh News & Observer reported that one of Potti’s co-authors on a 2007 Journal of Clinical Oncology (JCO) paper had requested a retraction: Continue reading A retraction in the Potti case?
Self-plagiarism alert: A very similar version of this post is being published online in Anesthesiology News, where one of us (AM) is managing editor.
A leading German anesthesiologist with more than 200 papers to his name has been accused of misrepresenting critical aspects of a paper — possibly including the data itself — published late last year in the journal Anesthesia & Analgesia.
In a retraction notice published online today, Steven L. Shafer, editor-in-chief of the journal, writes that Joachim Boldt and his coauthors failed to obtain approval from an institutional review board, did not get patient consent and did not follow up as promised with volunteers in their study, reported in the December 2009 article, “Cardiopulmonary Bypass Priming Using a High Dose of a Balanced Hydroxyethyl Starch Versus an Albumin-Based Priming System.”
In addition, the journal said, it has reason to suspect that data in the paper were fabricated, a possibility that is being investigated by German authorities. As the notice states: Continue reading Top German anesthesiologist’s cardiac surgery paper retracted over “very serious misrepresentations”
Both Retraction Watch bloggers are all too familiar with the artwork in dermatology journals. One of us, AM, used to write for Skin & Aging, while the other, IO, waited eagerly for issues of Cutis sent to his pediatrician father to show up on the coffee table. And IO recently broke the incredibly important story of “Mexican beer dermatitis.”
But we always trusted that the images we were looking at were real. A group of Egyptian dermatologists seems to have hit on a novel solution to the problem of uncooperative images: Continue reading Warts and all: Derm pub retracts plantar paper after author cries foul
In the blue corner: California researchers who reviewed trends in death rates among professional boxers.
In the red (ink) corner: The editors of Neurosurgery, who misclassified the article, leading to an abbreviated version appearing in print.
The decision: A retraction, followed by a reclassification and republication of the complete article: Continue reading They wuz robbed: Editorial TKO for boxing paper leads to retraction, republication